| 4.53 -0.18 (-3.82%) | 04-24 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.83  |
1-year : | 7.84 |
| Resists | First : | 5.84 |
Second : | 6.71 |
| Pivot price | 5.4  |
|||
| Supports | First : | 4.44 |
Second : | 3.69 |
| MAs | MA(5) : | 4.69 |
MA(20) : | 5.42 |
| MA(100) : | 4.32 |
MA(250) : | 2.67 |
|
| MACD | MACD : | -0.2 |
Signal : | 0 |
| %K %D | K(14,3) : | 5.7 |
D(3) : | 4.6 |
| RSI | RSI(14): 39.3 |
|||
| 52-week | High : | 6.71 | Low : | 1.11 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ABSI ] has closed above bottom band by 13.2%. Bollinger Bands are 60.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 4.9 - 4.93 | 4.93 - 4.95 |
| Low: | 4.4 - 4.44 | 4.44 - 4.47 |
| Close: | 4.48 - 4.53 | 4.53 - 4.57 |
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Tue, 23 Apr 2024
Absci (NASDAQ:ABSI) Stock Price Up 9.3% - MarketBeat
Tue, 23 Apr 2024
Both retail investors who control a good portion of Absci Corporation (NASDAQ:ABSI) along with institutions must be ... - Simply Wall St
Tue, 16 Apr 2024
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024 - GlobeNewswire
Wed, 10 Apr 2024
Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last? - Yahoo Finance
Fri, 01 Mar 2024
Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains? - Yahoo Finance
Wed, 28 Feb 2024
Absci Announces $75M Public Offering to Fuel AI Drug Creation - HIT Consultant
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 113 (M) |
| Held by Insiders | 8.069e+007 (%) |
| Held by Institutions | 22.6 (%) |
| Shares Short | 10,620 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -7.968e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -7 % |
| Return on Assets (ttm) | 171.3 % |
| Return on Equity (ttm) | -21.8 % |
| Qtrly Rev. Growth | 5.72e+006 % |
| Gross Profit (p.s.) | -33.04 |
| Sales Per Share | -20.71 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -1.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -65 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | -0.3 |
| Price to Book value | 0 |
| Price to Sales | -0.22 |
| Price to Cash Flow | 5.68 |
| Dividend | 0 |
| Forward Dividend | 1.048e+007 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|